Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:APLD NASDAQ:ARM NASDAQ:CRWV NASDAQ:NBIS NASDAQ:NVDA NASDAQ:RXRX NASDAQ:WRD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPLDApplied Digital$14.33-0.3%$12.75$3.31▼$17.60$3.76B6.6425.51 million shs15.72 million shsARMARM$135.48+3.1%$146.44$80.00▼$182.88$138.85B4.173.66 million shs3.27 million shsCRWVCoreWeave$87.48-2.7%$120.56$33.51▼$187.00$43.91BN/A28.49 million shs17.74 million shsNBISNebius Group$64.91-1.1%$58.74$14.09▼$75.96$15.48B3.5512.55 million shs5.46 million shsNVDANVIDIA$171.66+0.6%$172.55$86.62▼$184.48$4.15T2.1167.92 million shs140.97 million shsRXRXRecursion Pharmaceuticals$4.52-2.4%$5.40$3.79▼$12.36$2.01B0.9115.23 million shs14.71 million shsWRDWeRide$8.87-1.3%$9.09$6.03▼$44.00$2.60BN/A4.55 million shs2.82 million shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPLDApplied Digital-0.35%-13.67%-3.76%+3.39%+342.28%ARMARM+3.09%-4.96%-1.28%+1.78%+12.01%CRWVCoreWeave-2.67%-14.89%-21.78%-37.59%+8,747,999,900.00%NBISNebius Group-1.13%-9.90%+17.65%+34.44%+6,490,999,900.00%NVDANVIDIA+0.61%-4.72%-3.70%+21.13%+61.62%RXRXRecursion Pharmaceuticals-2.38%-7.00%-18.26%-17.67%-25.90%WRDWeRide-1.33%-7.31%+2.19%+0.57%+886,999,900.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPLDApplied Digital$14.33-0.3%$12.75$3.31▼$17.60$3.76B6.6425.51 million shs15.72 million shsARMARM$135.48+3.1%$146.44$80.00▼$182.88$138.85B4.173.66 million shs3.27 million shsCRWVCoreWeave$87.48-2.7%$120.56$33.51▼$187.00$43.91BN/A28.49 million shs17.74 million shsNBISNebius Group$64.91-1.1%$58.74$14.09▼$75.96$15.48B3.5512.55 million shs5.46 million shsNVDANVIDIA$171.66+0.6%$172.55$86.62▼$184.48$4.15T2.1167.92 million shs140.97 million shsRXRXRecursion Pharmaceuticals$4.52-2.4%$5.40$3.79▼$12.36$2.01B0.9115.23 million shs14.71 million shsWRDWeRide$8.87-1.3%$9.09$6.03▼$44.00$2.60BN/A4.55 million shs2.82 million shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPLDApplied Digital-0.35%-13.67%-3.76%+3.39%+342.28%ARMARM+3.09%-4.96%-1.28%+1.78%+12.01%CRWVCoreWeave-2.67%-14.89%-21.78%-37.59%+8,747,999,900.00%NBISNebius Group-1.13%-9.90%+17.65%+34.44%+6,490,999,900.00%NVDANVIDIA+0.61%-4.72%-3.70%+21.13%+61.62%RXRXRecursion Pharmaceuticals-2.38%-7.00%-18.26%-17.67%-25.90%WRDWeRide-1.33%-7.31%+2.19%+0.57%+886,999,900.00%Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPLDApplied Digital$144.19M25.99N/AN/A$2.21 per share6.48ARMARM$4.01B35.72$1.29 per share104.86$6.53 per share20.75CRWVCoreWeaveN/AN/AN/AN/AN/AN/ANBISNebius Group$117.50M130.23N/AN/A$13.80 per share4.70NVDANVIDIA$130.50B31.97$3.08 per share55.80$4.12 per share41.67RXRXRecursion Pharmaceuticals$58.84M33.35N/AN/A$2.61 per share1.73WRDWeRide$49.47M51.86N/AN/A$3.84 per share2.31Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPLDApplied Digital-$231.07M-$1.09N/AN/AN/A-107.22%-50.03%-13.45%10/8/2025 (Estimated)ARMARM$792M$0.66205.27116.798.7816.96%15.56%11.72%11/5/2025 (Estimated)CRWVCoreWeaveN/AN/A0.00∞N/AN/AN/AN/AN/ANBISNebius Group-$641.40M-$0.57N/AN/AN/AN/A-0.58%-0.50%9/9/2025 (Estimated)NVDANVIDIA$72.88B$3.5148.9143.131.2452.41%101.74%70.72%11/19/2025 (Estimated)RXRXRecursion Pharmaceuticals-$463.66M-$1.78N/AN/AN/A-1,004.91%-76.09%-54.29%11/5/2025 (Estimated)WRDWeRide-$350.09M-$2.79N/AN/AN/A-595.64%-49.03%-28.72%N/ALatest NVDA, CRWV, ARM, APLD, NBIS, WRD, and RXRX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails9/9/2025Q2 2025NBISNebius Group-$0.41-$0.44-$0.03N/A$95.60 million$47.60 million8/27/2025Q2 2026NVDANVIDIA$1.01$1.05+$0.04$1.08$45.65 billion$46.74 billion8/12/2025Q2 2025CRWVCoreWeave-$0.20-$0.27-$0.07-$0.60N/A$1.21 million8/5/2025Q2 2025RXRXRecursion Pharmaceuticals-$0.35-$0.41-$0.06-$0.41$15.38 million$19.10 million7/31/2025Q2 2025WRDWeRideN/A-$0.18N/A-$0.18N/A$17.75 million7/30/2025Q4 2025APLDApplied Digital-$0.12-$0.12N/A-$0.24$42.86 million$38.01 million7/30/2025Q1 2026ARMARM$0.34$0.35+$0.01$0.12$1.06 billion$1.05 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAPLDApplied DigitalN/AN/AN/AN/AN/AARMARMN/AN/AN/AN/AN/ACRWVCoreWeaveN/AN/AN/AN/AN/ANBISNebius GroupN/AN/AN/AN/AN/ANVDANVIDIA$0.040.02%N/A1.14%1 YearsRXRXRecursion PharmaceuticalsN/AN/AN/AN/AN/AWRDWeRideN/AN/AN/AN/AN/ALatest NVDA, CRWV, ARM, APLD, NBIS, WRD, and RXRX DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date8/27/2025NVDANVIDIAquarterly$0.010.02%9/11/20259/11/202510/2/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPLDApplied Digital1.360.770.77ARMARMN/A4.994.99CRWVCoreWeave2.790.520.52NBISNebius Group0.3114.7014.70NVDANVIDIA0.084.213.60RXRXRecursion Pharmaceuticals0.023.583.58WRDWeRide0.0111.0310.55Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPLDApplied Digital65.67%ARMARM7.53%CRWVCoreWeaveN/ANBISNebius Group21.90%NVDANVIDIA65.27%RXRXRecursion Pharmaceuticals89.06%WRDWeRideN/AInsider OwnershipCompanyInsider OwnershipAPLDApplied Digital11.81%ARMARMN/ACRWVCoreWeaveN/ANBISNebius GroupN/ANVDANVIDIA4.17%RXRXRecursion Pharmaceuticals8.43%WRDWeRide2.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPLDApplied Digital121261.52 million230.63 millionOptionableARMARM8,3301.06 billionN/ANot OptionableCRWVCoreWeave881488.57 millionN/AN/ANBISNebius Group1,371235.75 millionN/AN/ANVDANVIDIA36,00024.30 billion23.29 billionOptionableRXRXRecursion Pharmaceuticals400434.15 million397.55 millionOptionableWRDWeRide3,093289.26 million281.45 millionN/ANVDA, CRWV, ARM, APLD, NBIS, WRD, and RXRX HeadlinesRecent News About These CompaniesWeRide Rolls Out 24/7 Driverless Robotaxi Service In Guangzhou's Huangpu DistrictSeptember 4 at 6:34 AM | finance.yahoo.comWeRide Launches 24/7 Fully Driverless Robotaxi Service in Guangzhou's Huangpu DistrictSeptember 4 at 5:00 AM | globenewswire.comWeRide to Participate in September Investor ConferencesSeptember 2 at 11:00 PM | globenewswire.comMass Production in 2025! WeRide and Bosch Join Forces to Launch WePilotAiDrive, Ushering in a New Era of Intelligent Assisted DrivingAugust 27, 2025 | sohu.comSWeRide Unveils Shenzhen's First Fully Driverless Robobus LineAugust 26, 2025 | aol.comAWeRide and Shenzhen Bus Group Launch Shenzhen's First Fully Driverless Robobus Public Transport LineAugust 26, 2025 | globenewswire.comMissed Out on Nvidia? This AI Found 2 Stocks InsteadAugust 24, 2025 | msn.comWeRide unveils its new advanced driver assistance systemAugust 21, 2025 | msn.comWeRide's New AI System 'Sees And Acts' Like A Human DriverAugust 21, 2025 | aol.comAWeRide Unveils WePilot AiDrive, A One-Stage End-to-End ADAS Targeted for Mass Production in 2025August 21, 2025 | globenewswire.comGrab invests in WeRide stock as firms partner on robotaxi rolloutAugust 15, 2025 | investing.comWeRide Inc.: WeRide Secures Strategic Equity Investment from Grab, Partners to Deploy Robotaxis and Autonomous Shuttles in Southeast AsiaAugust 15, 2025 | finanznachrichten.deWeRide gets equity investment from Grab Holdings, announces Southeast Asia pactAugust 15, 2025 | msn.comWeRide Partners with Grab to Launch Robotaxis in Southeast AsiaAugust 15, 2025 | msn.comWeRide Secures Strategic Equity Investment from Grab, Partners to Deploy Robotaxis and Autonomous Shuttles in Southeast AsiaAugust 15, 2025 | globenewswire.comVirtu Financial LLC Purchases Shares of 53,290 WeRide Inc. (NASDAQ:WRD)August 14, 2025 | marketbeat.comWeRide Q2: Finally Robotaxi Revenue, But This Valuation Leaves No ChanceAugust 8, 2025 | seekingalpha.comWeRide Launches 24/7 Robotaxi Testing in Beijing, Advances Towards Full-Day ServiceAugust 6, 2025 | globenewswire.comWeRide (NASDAQ:WRD) Now Covered by Analysts at UBS GroupAugust 5, 2025 | marketbeat.comUBS Initiates Coverage of WeRide Inc. - Depositary Receipt () (WRD) with Buy RecommendationAugust 5, 2025 | msn.comCompetitive edge in autonomous driving will unlock profitability: WeRide CEOAugust 1, 2025 | youtube.comYNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThe Case for Buying NVIDIA Stock Ahead of the Robotics SurgeBy Thomas Hughes | August 20, 20253 AI Infrastructure Stocks Powering the Next Tech RevolutionBy Ryan Hasson | August 8, 2025Trump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli LillyBy Jordan Chussler | August 9, 2025Next-Gen Defense: 3 Stocks Riding the New Global Arms RaceBy Nathan Reiff | August 18, 20255 Stocks Insiders Are Selling That Analysts Say BuyBy Thomas Hughes | August 13, 2025NVDA, CRWV, ARM, APLD, NBIS, WRD, and RXRX Company DescriptionsApplied Digital NASDAQ:APLD$14.33 -0.05 (-0.35%) As of 09/4/2025 04:00 PM EasternApplied Digital Corporation designs, develops, and operates datacenters in North America. Its datacenters provide digital infrastructure solutions to the high-performance computing industry. The company also provides artificial intelligence cloud services, high performance computing datacenter hosting, and crypto datacenter hosting services. The company was formerly known as Applied Blockchain, Inc. and changed its name to Applied Digital Corporation in November 2022. Applied Digital Corporation is based in Dallas, Texas.ARM NASDAQ:ARM$135.48 +4.06 (+3.09%) Closing price 09/4/2025 04:00 PM EasternExtended Trading$135.56 +0.08 (+0.06%) As of 09/4/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.CoreWeave NASDAQ:CRWV$87.48 -2.40 (-2.67%) As of 09/4/2025 04:00 PM EasternCoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.Nebius Group NASDAQ:NBIS$64.91 -0.74 (-1.13%) Closing price 09/4/2025 04:00 PM EasternExtended Trading$65.08 +0.17 (+0.26%) As of 09/4/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nebius Group N.V., a technology company, builds intelligent products and services powered by machine learning and other technologies to help consumers and businesses navigate the online and offline world. The company's services include Nebius AI, an AI-centric cloud platform that offers infrastructure and computing capability for AI deployment and machine-learning oriented solutions; and Toloka AI that offers generative AI (GenAI) solutions at every stage of the GenAI lifecycle, such as data annotation and generation, model training and fine-tuning, and quality assessment of large language model for accuracy and reliability. It also offers Avride, an autonomous driving solution which targets ride-hailing, logistics, e-commerce, and food/grocery delivery as application domains, as well as focuses on autonomous vehicles and delivery robots; and TripleTen, an EdTech service that prepares specialists for STEM roles, and equipping them with essential technology skills. The company was formerly known as Yandex N.V. and changed its name to Nebius Group N.V. in August 2024. Nebius Group N.V. was founded in 1989 and is based in Schiphol, the Netherlands.NVIDIA NASDAQ:NVDA$171.66 +1.04 (+0.61%) Closing price 09/4/2025 04:00 PM EasternExtended Trading$171.32 -0.34 (-0.20%) As of 09/4/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NVIDIA Corporation provides graphics and compute and networking solutions in the United States, Taiwan, China, Hong Kong, and internationally. The Graphics segment offers GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; virtual GPU or vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse software for building and operating metaverse and 3D internet applications. The Compute & Networking segment comprises Data Center computing platforms and end-to-end networking platforms, including Quantum for InfiniBand and Spectrum for Ethernet; NVIDIA DRIVE automated-driving platform and automotive development agreements; Jetson robotics and other embedded platforms; NVIDIA AI Enterprise and other software; and DGX Cloud software and services. The company's products are used in gaming, professional visualization, data center, and automotive markets. It sells its products to original equipment manufacturers, original device manufacturers, system integrators and distributors, independent software vendors, cloud service providers, consumer internet companies, add-in board manufacturers, distributors, automotive manufacturers and tier-1 automotive suppliers, and other ecosystem participants. NVIDIA Corporation was incorporated in 1993 and is headquartered in Santa Clara, California.Recursion Pharmaceuticals NASDAQ:RXRX$4.52 -0.11 (-2.38%) Closing price 09/4/2025 04:00 PM EasternExtended Trading$4.54 +0.02 (+0.33%) As of 09/4/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.WeRide NASDAQ:WRD$8.87 -0.12 (-1.33%) As of 09/4/2025 04:00 PM EasternWeRide, Inc. engages in the development of an autonomous driving technology platform. It offers Robotaxi, Robobus, Robovan, Robosweeper, and advanced driving solutions, providing smart services in online ride-hailing, on-demand transport, urban logistics, and environmental sanitation. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir Insider Selling: Risk Signal or Normal Activity? Buy the Dip? GitLab’s Bullish Case Outweighs the Bears Affirm Crushes Earnings Expectations, Turns Bears into Believers Gold’s Explosive Rally: GDX ETF May Be the Fast Track to Profits Dollar Tree Plunges Into Buy-Zone: A Robust Rebound Is Expected Zscaler Shares Can Hit a Fresh High Before Year-End Why Qualcomm Is Outperforming NVIDIA After Months of Lagging Alphabet Stock Surges After Dodging Harsh Antitrust Remedies Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
